Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
Willscott E. Naugler,1,2Toshiharu Sakurai,1Sunhwa Kim,1Shin Maeda,3KyoungHyun Kim,1Ahmed M. Elsharkawy,1,4Michael Karin1*
Hepatocellular carcinoma (HCC), the most common liver cancer,occurs mainly in men. Similar gender disparity is seen in micegiven a chemical carcinogen, diethylnitrosamine (DEN). DEN administrationcaused greater increases in serum interleukin-6 (IL-6) concentrationin males than it did in females. Furthermore, ablation of IL-6abolished the gender differences in hepatocarcinogenesis inmice. DEN exposure promoted production of IL-6 in Kupffer cells(KCs) in a manner dependent on the Toll-like receptor adaptorprotein MyD88, ablation of which also protected male mice fromDEN-induced hepatocarcinogenesis. Estrogen inhibited secretionof IL-6 from KCs exposed to necrotic hepatocytes and reducedcirculating concentrations of IL-6 in DEN-treated male mice.We propose that estrogen-mediated inhibition of IL-6 productionby KCs reduces liver cancer risk in females, and these findingsmay be used to prevent HCC in males.
1 Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology and Cancer Center, University of California, San Diego, CA 93093, USA. 2 Department of Medicine, Division of Gastroenterology, University of California, San Diego, CA 93093, USA. 3 Division of Gastroenterology, The Institute for Adult Diseases, Asahi Life Foundation, 1-6-1 Marunouchi, Chiyoda-ku, Tokyo 100-0005, Japan. 4 Liver Research Group, University of Newcastle, Newcastle Upon Tyne NE2 4HH, UK.
* To whom correspondence should be addressed: 9500 Gilman Road, Mail Code 0723 University of California, San Diego, San Diego, CA 920930636, USA. E-mail: karinoffice{at}ucsd.edu
S. Seshadri, Y. Kannan, S. Mitra, J. Parker-Barnes, and M. D. Wewers (2009)
J. Immunol.
183, 5358-5368
|Abstract »|Full Text »|PDF »
Gender Disparities in Metastatic Colorectal Cancer Survival.
A. Hendifar, D. Yang, F. Lenz, G. Lurje, A. Pohl, C. Lenz, Y. Ning, W. Zhang, and H.-J. Lenz (2009)
Clin. Cancer Res.
15, 6391-6397
|Abstract »|Full Text »|PDF »
MicroRNA Expression, Survival, and Response to Interferon in Liver Cancer.
J. Ji, J. Shi, A. Budhu, Z. Yu, M. Forgues, S. Roessler, S. Ambs, Y. Chen, P. S. Meltzer, C. M. Croce, et al. (2009)
N. Engl. J. Med.
361, 1437-1447
|Abstract »|Full Text »|PDF »
Micromanaging Cancer.
J. Lieberman (2009)
N. Engl. J. Med.
361, 1500-1501
|Full Text »|PDF »
Influence of interleukin-6 G-174C gene polymorphism on coronary artery disease, cardiovascular complications and mortality in dialysis patients.
S. Aker, C. Bantis, P. Reis, N. Kuhr, C. Schwandt, B. Grabensee, P. Heering, and K. Ivens (2009)
Nephrol. Dial. Transplant.
24, 2847-2851
|Abstract »|Full Text »|PDF »
The Constitutive Active/Androstane Receptor Facilitates Unique Phenobarbital-Induced Expression Changes of Genes Involved in Key Pathways in Precancerous Liver and Liver Tumors.
J. M. Phillips, L. D. Burgoon, and J. I. Goodman (2009)
Toxicol. Sci.
110, 319-333
|Abstract »|Full Text »|PDF »
Hepatitis B Virus Infection and Hepatocellular Carcinoma Among Parous Taiwanese Women: Nationwide Cohort Study.
C.-W. Fwu, Y.-C. Chien, G. D. Kirk, K. E. Nelson, S.-L. You, H.-S. Kuo, M. Feinleib, and C.-J. Chen (2009)
J Natl Cancer Inst
101, 1019-1027
|Abstract »|Full Text »|PDF »
Estrogen Inhibits ATR Signaling to Cell Cycle Checkpoints and DNA Repair.
A. Pedram, M. Razandi, A. J. Evinger, E. Lee, and E. R. Levin (2009)
Mol. Biol. Cell
20, 3374-3389
|Abstract »|Full Text »|PDF »
Obesity Impairs Wound Healing in Ovariectomized Female Mice.
V. B. HOLCOMB, V. A. KECK, J. C. BARRETT, J. HONG, S. K. LIBUTTI, and N. P. NUNEZ (2009)
In Vivo
23, 515-518
|Abstract »|Full Text »|PDF »
The Epidermal Growth Factor Receptor: A Link Between Inflammation and Liver Cancer.
C. Berasain, M. J. Perugorria, M. U. Latasa, J. Castillo, S. Goni, M. Santamaria, J. Prieto, and M. A. Avila (2009)
Experimental Biology and Medicine
234, 713-725
|Abstract »|Full Text »|PDF »
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability.
F. Colotta, P. Allavena, A. Sica, C. Garlanda, and A. Mantovani (2009)
Carcinogenesis
30, 1073-1081
|Abstract »|Full Text »|PDF »
Milk fat globule epidermal growth factor-8 blockade triggers tumor destruction through coordinated cell-autonomous and immune-mediated mechanisms.
M. Jinushi, M. Sato, A. Kanamoto, A. Itoh, S. Nagai, S. Koyasu, G. Dranoff, and H. Tahara (2009)
J. Exp. Med.
206, 1317-1326
|Abstract »|Full Text »|PDF »
Toll-like receptors as targets in chronic liver diseases.
C/EBP{beta} regulates body composition, energy balance-related hormones and tumor growth.
J. Staiger, M. J. Lueben, D. Berrigan, R. Malik, S. N. Perkins, S. D. Hursting, and P. F. Johnson (2009)
Carcinogenesis
30, 832-840
|Abstract »|Full Text »|PDF »
Molecular insights into {beta}-galactoside {alpha}2,6-sialyltransferase secretion in vivo.
S. Kitazume, R. Oka, K. Ogawa, S. Futakawa, Y. Hagiwara, H. Takikawa, M. Kato, A. Kasahara, E. Miyoshi, N. Taniguchi, et al. (2009)
Glycobiology
19, 479-487
|Abstract »|Full Text »|PDF »
Predominant modifier of extreme liver cancer susceptibility in C57BR/cdJ female mice localized to 6 Mb on chromosome 17.
S. E.-M. Peychal, A. Bilger, H. C. Pitot, and N. R. Drinkwater (2009)
Carcinogenesis
30, 879-885
|Abstract »|Full Text »|PDF »
Sex-Modified Effect of Hepatitis B Virus Infection on Mortality From Primary Liver Cancer.
N. Wang, Y. Zheng, X. Yu, W. Lin, Y. Chen, and Q. Jiang (2009)
Am. J. Epidemiol.
169, 990-995
|Abstract »|Full Text »|PDF »
Macrophages in Hepatitis B and Hepatitis C Virus Infections.
Sex Disparities in Cancer Incidence by Period and Age.
M. B. Cook, S. M. Dawsey, N. D. Freedman, P. D. Inskip, S. M. Wichner, S. M. Quraishi, S. S. Devesa, and K. A. McGlynn (2009)
Cancer Epidemiol. Biomarkers Prev.
18, 1174-1182
|Abstract »|Full Text »|PDF »
Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
N Chaput, S Louafi, A Bardier, F Charlotte, J-C Vaillant, F Menegaux, M Rosenzwajg, F Lemoine, D Klatzmann, and J Taieb (2009)
Gut
58, 520-529
|Abstract »|Full Text »|PDF »
Multiple Genes Exhibit Phenobarbital-Induced Constitutive Active/Androstane Receptor-Mediated DNA Methylation Changes during Liver Tumorigenesis and in Liver Tumors.
Protein Kinase C{zeta} Represses the Interleukin-6 Promoter and Impairs Tumorigenesis In Vivo.
A. S. Galvez, A. Duran, J. F. Linares, P. Pathrose, E. A. Castilla, S. Abu-Baker, M. Leitges, M. T. Diaz-Meco, and J. Moscat (2009)
Mol. Cell. Biol.
29, 104-115
|Abstract »|Full Text »|PDF »
Oesophageal and gastric intestinal-type adenocarcinomas show the same male predominance due to a 17 year delayed development in females.
M H Derakhshan, S Liptrot, J Paul, I L Brown, D Morrison, and K E L McColl (2009)
Gut
58, 16-23
|Abstract »|Full Text »|PDF »
ERK-mediated regulation of leukotriene biosynthesis by androgens: A molecular basis for gender differences in inflammation and asthma.
C. Pergola, G. Dodt, A. Rossi, E. Neunhoeffer, B. Lawrenz, H. Northoff, B. Samuelsson, O. Radmark, L. Sautebin, and O. Werz (2008)
PNAS
105, 19881-19886
|Abstract »|Full Text »|PDF »
Hepatitis C Virus Core Protein Augments Androgen Receptor-Mediated Signaling.
T. Kanda, R. Steele, R. Ray, and R. B. Ray (2008)
J. Virol.
82, 11066-11072
|Abstract »|Full Text »|PDF »
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma.
Y. Hoshida, A. Villanueva, M. Kobayashi, J. Peix, D. Y. Chiang, A. Camargo, S. Gupta, J. Moore, M. J. Wrobel, J. Lerner, et al. (2008)
N. Engl. J. Med.
359, 1995-2004
|Abstract »|Full Text »|PDF »
Case-control analysis of nucleotide excision repair pathway and the risk of renal cell carcinoma.
J. Lin, X. Pu, W. Wang, S. Matin, N. M. Tannir, C. G. Wood, and X. Wu (2008)
Carcinogenesis
29, 2112-2119
|Abstract »|Full Text »|PDF »
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6.
Interleukin (IL) 1{beta} Induction of IL-6 Is Mediated by a Novel Phosphatidylinositol 3-Kinase-dependent AKT/I{kappa}B Kinase {alpha} Pathway Targeting Activator Protein-1.
Endothelial Lipase Is Increased In Vivo by Inflammation in Humans.
K. O. Badellino, M. L. Wolfe, M. P. Reilly, and D. J. Rader (2008)
Circulation
117, 678-685
|Abstract »|Full Text »|PDF »
17{beta}-Estradiol Alters the Activity of Conventional and IFN-Producing Killer Dendritic Cells.
M. C. Siracusa, M. G. Overstreet, F. Housseau, A. L. Scott, and S. L. Klein (2008)
J. Immunol.
180, 1423-1431
|Abstract »|Full Text »|PDF »
Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3.
K. J. Riehle, J. S. Campbell, R. S. McMahan, M. M. Johnson, R. P. Beyer, T. K. Bammler, and N. Fausto (2008)
J. Exp. Med.
205, 91-103
|Abstract »|Full Text »|PDF »
Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis.
J. B. Swann, M. D. Vesely, A. Silva, J. Sharkey, S. Akira, R. D. Schreiber, and M. J. Smyth (2008)
PNAS
105, 652-656
|Abstract »|Full Text »|PDF »
Crucial Role of Phospholipase C{varepsilon} in Skin Inflammation Induced by Tumor-Promoting Phorbol Ester.
S. Ikuta, H. Edamatsu, M. Li, L. Hu, and T. Kataoka (2008)
Cancer Res.
68, 64-72
|Abstract »|Full Text »|PDF »
Hepatocellular Carcinoma Associated with Liver-Gender Disruption in Male Mice.
A. B. Rogers, E. J. Theve, Y. Feng, R. C. Fry, K. Taghizadeh, K. M. Clapp, C. Boussahmain, K. S. Cormier, and J. G. Fox (2007)
Cancer Res.
67, 11536-11546
|Abstract »|Full Text »|PDF »
Hepatocellular Carcinoma and Sex.
J. Wands (2007)
N. Engl. J. Med.
357, 1974-1976
|Full Text »|PDF »